Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million

investors.com/news/technology/sage-therapeutics-takeover-supernus-pharmaceuticals

Supernus Pharmaceuticals agreed Monday to buy beleaguered biotech Sage Therapeutics in a deal worth up to $561 million.
The post Beleaguered Sage Snapped Up In Deal Worth Up To $561 Million appeared first on Investor's Business Daily.

This story appeared on investors.com, 2025-06-16 13:14:04.
The Entire Business World on a Single Page. Free to Use →